nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Breast feeding—Medroxyprogesterone Acetate—uterine cancer	0.0556	0.0556	CcSEcCtD
Gadobutrol—Pregnancy—Progesterone—uterine cancer	0.0378	0.0378	CcSEcCtD
Gadobutrol—Pregnancy—Medroxyprogesterone Acetate—uterine cancer	0.0342	0.0342	CcSEcCtD
Gadobutrol—Injection site pain—Medroxyprogesterone Acetate—uterine cancer	0.0238	0.0238	CcSEcCtD
Gadobutrol—Abnormal vision—Progesterone—uterine cancer	0.0187	0.0187	CcSEcCtD
Gadobutrol—Hot flush—Progesterone—uterine cancer	0.0166	0.0166	CcSEcCtD
Gadobutrol—Menopausal symptoms—Progesterone—uterine cancer	0.0165	0.0165	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Progesterone—uterine cancer	0.0161	0.0161	CcSEcCtD
Gadobutrol—Hot flush—Medroxyprogesterone Acetate—uterine cancer	0.0151	0.0151	CcSEcCtD
Gadobutrol—Menopausal symptoms—Medroxyprogesterone Acetate—uterine cancer	0.0149	0.0149	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.0146	0.0146	CcSEcCtD
Gadobutrol—Infection—Carboplatin—uterine cancer	0.0145	0.0145	CcSEcCtD
Gadobutrol—Sweating increased—Progesterone—uterine cancer	0.0131	0.0131	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.0129	0.0129	CcSEcCtD
Gadobutrol—Pain—Carboplatin—uterine cancer	0.0124	0.0124	CcSEcCtD
Gadobutrol—Pollakiuria—Progesterone—uterine cancer	0.0124	0.0124	CcSEcCtD
Gadobutrol—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.0119	0.0119	CcSEcCtD
Gadobutrol—Body temperature increased—Carboplatin—uterine cancer	0.0115	0.0115	CcSEcCtD
Gadobutrol—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.0113	0.0113	CcSEcCtD
Gadobutrol—Urine abnormality—Epirubicin—uterine cancer	0.0111	0.0111	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Epirubicin—uterine cancer	0.0104	0.0104	CcSEcCtD
Gadobutrol—Visual impairment—Progesterone—uterine cancer	0.0104	0.0104	CcSEcCtD
Gadobutrol—Urine abnormality—Doxorubicin—uterine cancer	0.0103	0.0103	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Doxorubicin—uterine cancer	0.00967	0.00967	CcSEcCtD
Gadobutrol—Parosmia—Epirubicin—uterine cancer	0.00947	0.00947	CcSEcCtD
Gadobutrol—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.0094	0.0094	CcSEcCtD
Gadobutrol—Parosmia—Doxorubicin—uterine cancer	0.00876	0.00876	CcSEcCtD
Gadobutrol—Vertigo—Progesterone—uterine cancer	0.00842	0.00842	CcSEcCtD
Gadobutrol—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00831	0.00831	CcSEcCtD
Gadobutrol—Palpitations—Progesterone—uterine cancer	0.00828	0.00828	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Etoposide—uterine cancer	0.00822	0.00822	CcSEcCtD
Gadobutrol—Convulsion—Progesterone—uterine cancer	0.00812	0.00812	CcSEcCtD
Gadobutrol—Dry mouth—Progesterone—uterine cancer	0.0078	0.0078	CcSEcCtD
Gadobutrol—Anaphylactic shock—Progesterone—uterine cancer	0.00764	0.00764	CcSEcCtD
Gadobutrol—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00763	0.00763	CcSEcCtD
Gadobutrol—Infection—Progesterone—uterine cancer	0.00759	0.00759	CcSEcCtD
Gadobutrol—Injection site pain—Epirubicin—uterine cancer	0.00753	0.00753	CcSEcCtD
Gadobutrol—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.0075	0.0075	CcSEcCtD
Gadobutrol—Hyperhidrosis—Progesterone—uterine cancer	0.00739	0.00739	CcSEcCtD
Gadobutrol—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00735	0.00735	CcSEcCtD
Gadobutrol—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00707	0.00707	CcSEcCtD
Gadobutrol—Injection site pain—Doxorubicin—uterine cancer	0.00696	0.00696	CcSEcCtD
Gadobutrol—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00693	0.00693	CcSEcCtD
Gadobutrol—Insomnia—Progesterone—uterine cancer	0.00691	0.00691	CcSEcCtD
Gadobutrol—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00688	0.00688	CcSEcCtD
Gadobutrol—Paraesthesia—Progesterone—uterine cancer	0.00686	0.00686	CcSEcCtD
Gadobutrol—Dyspnoea—Progesterone—uterine cancer	0.00682	0.00682	CcSEcCtD
Gadobutrol—Sweating increased—Etoposide—uterine cancer	0.0067	0.0067	CcSEcCtD
Gadobutrol—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.0067	0.0067	CcSEcCtD
Gadobutrol—Pain—Progesterone—uterine cancer	0.00654	0.00654	CcSEcCtD
Gadobutrol—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00626	0.00626	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Progesterone—uterine cancer	0.00625	0.00625	CcSEcCtD
Gadobutrol—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00622	0.00622	CcSEcCtD
Gadobutrol—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00618	0.00618	CcSEcCtD
Gadobutrol—Abdominal pain—Progesterone—uterine cancer	0.00604	0.00604	CcSEcCtD
Gadobutrol—Body temperature increased—Progesterone—uterine cancer	0.00604	0.00604	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00566	0.00566	CcSEcCtD
Gadobutrol—Hypersensitivity—Progesterone—uterine cancer	0.00563	0.00563	CcSEcCtD
Gadobutrol—Hypoaesthesia—Etoposide—uterine cancer	0.00548	0.00548	CcSEcCtD
Gadobutrol—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00548	0.00548	CcSEcCtD
Gadobutrol—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00548	0.00548	CcSEcCtD
Gadobutrol—Infection—Dactinomycin—uterine cancer	0.00537	0.00537	CcSEcCtD
Gadobutrol—Abnormal vision—Epirubicin—uterine cancer	0.00536	0.00536	CcSEcCtD
Gadobutrol—Diarrhoea—Progesterone—uterine cancer	0.00523	0.00523	CcSEcCtD
Gadobutrol—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.0051	0.0051	CcSEcCtD
Gadobutrol—Dizziness—Progesterone—uterine cancer	0.00505	0.00505	CcSEcCtD
Gadobutrol—Abnormal vision—Doxorubicin—uterine cancer	0.00496	0.00496	CcSEcCtD
Gadobutrol—Vomiting—Progesterone—uterine cancer	0.00486	0.00486	CcSEcCtD
Gadobutrol—Rash—Progesterone—uterine cancer	0.00482	0.00482	CcSEcCtD
Gadobutrol—Dermatitis—Progesterone—uterine cancer	0.00482	0.00482	CcSEcCtD
Gadobutrol—Headache—Progesterone—uterine cancer	0.00479	0.00479	CcSEcCtD
Gadobutrol—Hot flush—Epirubicin—uterine cancer	0.00477	0.00477	CcSEcCtD
Gadobutrol—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00474	0.00474	CcSEcCtD
Gadobutrol—Menopausal symptoms—Epirubicin—uterine cancer	0.00473	0.00473	CcSEcCtD
Gadobutrol—Dysgeusia—Etoposide—uterine cancer	0.00469	0.00469	CcSEcCtD
Gadobutrol—Pain—Dactinomycin—uterine cancer	0.00462	0.00462	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00461	0.00461	CcSEcCtD
Gadobutrol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00458	0.00458	CcSEcCtD
Gadobutrol—Nausea—Progesterone—uterine cancer	0.00454	0.00454	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00442	0.00442	CcSEcCtD
Gadobutrol—Hot flush—Doxorubicin—uterine cancer	0.00441	0.00441	CcSEcCtD
Gadobutrol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.0044	0.0044	CcSEcCtD
Gadobutrol—Menopausal symptoms—Doxorubicin—uterine cancer	0.00437	0.00437	CcSEcCtD
Gadobutrol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00437	0.00437	CcSEcCtD
Gadobutrol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00436	0.00436	CcSEcCtD
Gadobutrol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00434	0.00434	CcSEcCtD
Gadobutrol—Vertigo—Etoposide—uterine cancer	0.0043	0.0043	CcSEcCtD
Gadobutrol—Abdominal pain—Dactinomycin—uterine cancer	0.00427	0.00427	CcSEcCtD
Gadobutrol—Body temperature increased—Dactinomycin—uterine cancer	0.00427	0.00427	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00426	0.00426	CcSEcCtD
Gadobutrol—Convulsion—Etoposide—uterine cancer	0.00415	0.00415	CcSEcCtD
Gadobutrol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00411	0.00411	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Epirubicin—uterine cancer	0.00407	0.00407	CcSEcCtD
Gadobutrol—Hypersensitivity—Dactinomycin—uterine cancer	0.00398	0.00398	CcSEcCtD
Gadobutrol—Anaphylactic shock—Etoposide—uterine cancer	0.00391	0.00391	CcSEcCtD
Gadobutrol—Infection—Etoposide—uterine cancer	0.00388	0.00388	CcSEcCtD
Gadobutrol—Hyperhidrosis—Etoposide—uterine cancer	0.00378	0.00378	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00377	0.00377	CcSEcCtD
Gadobutrol—Diarrhoea—Dactinomycin—uterine cancer	0.0037	0.0037	CcSEcCtD
Gadobutrol—Pollakiuria—Epirubicin—uterine cancer	0.00356	0.00356	CcSEcCtD
Gadobutrol—Paraesthesia—Etoposide—uterine cancer	0.00351	0.00351	CcSEcCtD
Gadobutrol—Dyspnoea—Etoposide—uterine cancer	0.00349	0.00349	CcSEcCtD
Gadobutrol—Vomiting—Dactinomycin—uterine cancer	0.00344	0.00344	CcSEcCtD
Gadobutrol—Rash—Dactinomycin—uterine cancer	0.00341	0.00341	CcSEcCtD
Gadobutrol—Pain—Etoposide—uterine cancer	0.00334	0.00334	CcSEcCtD
Gadobutrol—Pollakiuria—Doxorubicin—uterine cancer	0.00329	0.00329	CcSEcCtD
Gadobutrol—Nausea—Dactinomycin—uterine cancer	0.00321	0.00321	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Etoposide—uterine cancer	0.0032	0.0032	CcSEcCtD
Gadobutrol—Abdominal pain—Etoposide—uterine cancer	0.00309	0.00309	CcSEcCtD
Gadobutrol—Body temperature increased—Etoposide—uterine cancer	0.00309	0.00309	CcSEcCtD
Gadobutrol—Hypoaesthesia—Epirubicin—uterine cancer	0.00307	0.00307	CcSEcCtD
Gadobutrol—Visual impairment—Epirubicin—uterine cancer	0.00297	0.00297	CcSEcCtD
Gadobutrol—Hypersensitivity—Etoposide—uterine cancer	0.00288	0.00288	CcSEcCtD
Gadobutrol—Hypoaesthesia—Doxorubicin—uterine cancer	0.00284	0.00284	CcSEcCtD
Gadobutrol—Visual impairment—Doxorubicin—uterine cancer	0.00275	0.00275	CcSEcCtD
Gadobutrol—Diarrhoea—Etoposide—uterine cancer	0.00268	0.00268	CcSEcCtD
Gadobutrol—Dysgeusia—Epirubicin—uterine cancer	0.00263	0.00263	CcSEcCtD
Gadobutrol—Dizziness—Etoposide—uterine cancer	0.00259	0.00259	CcSEcCtD
Gadobutrol—Vomiting—Etoposide—uterine cancer	0.00249	0.00249	CcSEcCtD
Gadobutrol—Rash—Etoposide—uterine cancer	0.00247	0.00247	CcSEcCtD
Gadobutrol—Dermatitis—Etoposide—uterine cancer	0.00246	0.00246	CcSEcCtD
Gadobutrol—Headache—Etoposide—uterine cancer	0.00245	0.00245	CcSEcCtD
Gadobutrol—Dysgeusia—Doxorubicin—uterine cancer	0.00243	0.00243	CcSEcCtD
Gadobutrol—Vertigo—Epirubicin—uterine cancer	0.00241	0.00241	CcSEcCtD
Gadobutrol—Palpitations—Epirubicin—uterine cancer	0.00237	0.00237	CcSEcCtD
Gadobutrol—Convulsion—Epirubicin—uterine cancer	0.00233	0.00233	CcSEcCtD
Gadobutrol—Nausea—Etoposide—uterine cancer	0.00232	0.00232	CcSEcCtD
Gadobutrol—Dry mouth—Epirubicin—uterine cancer	0.00224	0.00224	CcSEcCtD
Gadobutrol—Vertigo—Doxorubicin—uterine cancer	0.00223	0.00223	CcSEcCtD
Gadobutrol—Palpitations—Doxorubicin—uterine cancer	0.0022	0.0022	CcSEcCtD
Gadobutrol—Anaphylactic shock—Epirubicin—uterine cancer	0.00219	0.00219	CcSEcCtD
Gadobutrol—Infection—Epirubicin—uterine cancer	0.00218	0.00218	CcSEcCtD
Gadobutrol—Convulsion—Doxorubicin—uterine cancer	0.00215	0.00215	CcSEcCtD
Gadobutrol—Hyperhidrosis—Epirubicin—uterine cancer	0.00212	0.00212	CcSEcCtD
Gadobutrol—Dry mouth—Doxorubicin—uterine cancer	0.00207	0.00207	CcSEcCtD
Gadobutrol—Anaphylactic shock—Doxorubicin—uterine cancer	0.00203	0.00203	CcSEcCtD
Gadobutrol—Infection—Doxorubicin—uterine cancer	0.00201	0.00201	CcSEcCtD
Gadobutrol—Insomnia—Epirubicin—uterine cancer	0.00198	0.00198	CcSEcCtD
Gadobutrol—Paraesthesia—Epirubicin—uterine cancer	0.00197	0.00197	CcSEcCtD
Gadobutrol—Hyperhidrosis—Doxorubicin—uterine cancer	0.00196	0.00196	CcSEcCtD
Gadobutrol—Dyspnoea—Epirubicin—uterine cancer	0.00195	0.00195	CcSEcCtD
Gadobutrol—Pain—Epirubicin—uterine cancer	0.00187	0.00187	CcSEcCtD
Gadobutrol—Insomnia—Doxorubicin—uterine cancer	0.00183	0.00183	CcSEcCtD
Gadobutrol—Paraesthesia—Doxorubicin—uterine cancer	0.00182	0.00182	CcSEcCtD
Gadobutrol—Dyspnoea—Doxorubicin—uterine cancer	0.00181	0.00181	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Epirubicin—uterine cancer	0.00179	0.00179	CcSEcCtD
Gadobutrol—Pain—Doxorubicin—uterine cancer	0.00173	0.00173	CcSEcCtD
Gadobutrol—Abdominal pain—Epirubicin—uterine cancer	0.00173	0.00173	CcSEcCtD
Gadobutrol—Body temperature increased—Epirubicin—uterine cancer	0.00173	0.00173	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00166	0.00166	CcSEcCtD
Gadobutrol—Hypersensitivity—Epirubicin—uterine cancer	0.00161	0.00161	CcSEcCtD
Gadobutrol—Body temperature increased—Doxorubicin—uterine cancer	0.0016	0.0016	CcSEcCtD
Gadobutrol—Abdominal pain—Doxorubicin—uterine cancer	0.0016	0.0016	CcSEcCtD
Gadobutrol—Diarrhoea—Epirubicin—uterine cancer	0.0015	0.0015	CcSEcCtD
Gadobutrol—Hypersensitivity—Doxorubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Gadobutrol—Dizziness—Epirubicin—uterine cancer	0.00145	0.00145	CcSEcCtD
Gadobutrol—Vomiting—Epirubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Gadobutrol—Diarrhoea—Doxorubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Gadobutrol—Rash—Epirubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Gadobutrol—Dermatitis—Epirubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Gadobutrol—Headache—Epirubicin—uterine cancer	0.00137	0.00137	CcSEcCtD
Gadobutrol—Dizziness—Doxorubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Gadobutrol—Nausea—Epirubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Gadobutrol—Vomiting—Doxorubicin—uterine cancer	0.00129	0.00129	CcSEcCtD
Gadobutrol—Rash—Doxorubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Gadobutrol—Dermatitis—Doxorubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Gadobutrol—Headache—Doxorubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Gadobutrol—Nausea—Doxorubicin—uterine cancer	0.0012	0.0012	CcSEcCtD
